CLX (STOCKS)
Clorox Company
$125.590000
+4.140000 (+3.41%)
Prev close: $121.450000
Company Information
- Exchange
- XNYS
- Sector
- Consumer Non-Durables
- Industry
- Household/Personal Care
- CEO
- Linda Rendle
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15,497.97M
- Employees
- 7,600
- P/E (TTM)
- 19.84
- P/B (TTM)
- -117.46
- Dividend Yield
- 406.75%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
1
Buy
16
Hold
8
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$1.39 | $1.45 | -0.0577 | -3.99% |
|
Sep 2025 (Q1)
|
$0.85 | $0.79 | +0.0554 | +6.97% |
|
Jun 2025 (Q4)
|
$2.87 | $2.23 | +0.6400 | +28.70% |
|
Mar 2025 (Q3)
|
$1.45 | $1.58 | -0.1311 | -8.29% |
Financial Statements
| Revenues | $6.76B |
| Benefits Costs and Expenses | $5.77B |
| Cost Of Revenue | $3.77B |
| Costs And Expenses | $5.77B |
| Gross Profit | $2.99B |
| Operating Expenses | $2.00B |
| Selling, General, and Administrative Expenses | $1.10B |
| Research and Development | $116.00M |
| Other Operating Expenses | $782.00M |
| Operating Income/Loss | $986.00M |
| Income/Loss Before Equity Method Investments | $983.00M |
| Income/Loss From Continuing Operations After Tax | $770.00M |
| Income/Loss From Continuing Operations Before Tax | $986.00M |
| Income/Loss From Equity Method Investments | $3.00M |
| Income Tax Expense/Benefit | $216.00M |
| Income Tax Expense/Benefit, Deferred | $93.00M |
| Interest Expense, Operating | $93.00M |
| Net Income/Loss | $770.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $15.00M |
| Net Income/Loss Attributable To Parent | $755.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $755.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.14 |
| Diluted Earnings Per Share | $6.12 |
| Basic Average Shares | 367,480,000 |
| Diluted Average Shares | 368,818,000 |
| Assets | $5.61B |
| Current Assets | $1.73B |
| Accounts Receivable | $671.00M |
| Inventory | $608.00M |
| Other Current Assets | $449.00M |
| Noncurrent Assets | $3.89B |
| Fixed Assets | $1.25B |
| Other Non-current Assets | $2.64B |
| Liabilities | $5.58B |
| Current Liabilities | $2.35B |
| Noncurrent Liabilities | $3.23B |
| Equity | $35.00M |
| Equity Attributable To Noncontrolling Interest | $160.00M |
| Equity Attributable To Parent | -$125.00M |
| Liabilities And Equity | $5.61B |
| Net Cash Flow From Operating Activities | $984.00M |
| Net Cash Flow From Operating Activities, Continuing | $984.00M |
| Net Cash Flow From Investing Activities | -$206.00M |
| Net Cash Flow From Investing Activities, Continuing | -$206.00M |
| Net Cash Flow From Financing Activities | -$847.00M |
| Net Cash Flow From Financing Activities, Continuing | -$847.00M |
| Exchange Gains/Losses | $4.00M |
| Net Cash Flow | -$65.00M |
| Net Cash Flow, Continuing | -$69.00M |
| Comprehensive Income/Loss | $792.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $15.00M |
| Comprehensive Income/Loss Attributable To Parent | $777.00M |
| Other Comprehensive Income/Loss | $22.00M |